Warning letter
Chinese Peptide Company: warning letter of Mar 28, 2012
FDA warning letter UCM306518 · Center for Drug Evaluation and Research
Key facts
| Reference number | UCM306518 |
|---|---|
| Company | Chinese Peptide Company |
| Subject | Failure to Register and List |
| Issue date | Mar 28, 2012 |
| Posted date | Mar 28, 2012 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Devices |
| CFR sections cited | 207, 207.25(b) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: